5篇
您的检索式：作者名="Phillipp Hartmann"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Toll-Like Receptor 2–Mediated Intestinal Injury and Enteric Tumor Necrosis Factor Receptor I Contribute to Liver Fibrosis in Mice显示文摘 | Phillipp Hartmann Michael Haimerl Magdalena Mazagova David A. Brenner Bernd Schnabl | 2012 | Gastroenterology2012，，5： | 2 |
| 2 | Deficiency of intestinal mucin‐2 ameliorates experimental alcoholic liver disease in mice显示文摘 | Phillipp Hartmann Peng Chen Hui J. Wang Lirui Wang Declan F. McCole Katharina Brandl Peter St?rkel Clara Belzer Claus Hellerbrand Hidekazu Tsukamoto Samuel B. Ho Bernd Schnabl | 2013 | Hepatology2013，，： | 1 |
| 3 | Methods to determine intestinal permeability and bacterial translocation during liver disease显示文摘 | Lirui Wang Cristina Llorente Phillipp Hartmann An-Ming Yang Peng Chen Bernd Schnabl | 2015 | Journal of Immunological Methods2015，，： | 1 |
| 4 | Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure显示文摘Background:Cirrhosis with acute decompensation(AD)and acute-on-chronic liver failure(ACLF)are characterized by high morbidity and mortality.Cytolysin,a toxin from Enterococcus faecalis(E.faecalis),is associated with mortality in alcohol-associated hepatitis(AH).It is unclear whether cytolysin also contributes to disease severity in AD and ACLF.Methods:We studied the role of fecal cytolysin in 78 cirrhotic patients with AD/ACLF.Bacterial DNA from fecal samples was extracted and real-time quantitative polymerase chain reaction(PCR)was performed.The association between fecal cytolysin and liver disease severity in cirrhosis with AD or ACLF was analyzed.Results:Fecal cytolysin and E.faecalis abundance did not predict chronic liver failure(CLIF-C)AD and ACLF scores.Presence of fecal cytolysin was not associated with other liver disease markers,including Fibrosis-4(FIB-4)index,‘Age,serum Bilirubin,INR,and serum Creatinine(ABIC)’score,Child-Pugh score,model for end-stage liver disease(MELD)nor MELD-Na scores in AD or ACLF patients.Conclusions:Fecal cytolysin does not predict disease severity in AD and ACLF patients.The predictive value of fecal cytolysin positivity for mortality appears to be restricted to AH. | Phillipp Hartmann Sonja Lang Robert Schierwagen Sabine Klein Michael Praktiknjo Jonel Trebicka Bernd Schnabl | 2023 | Hepatobiliary & Pancreatic Diseases International2023，22，5： | 0 |
| 5 | Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease显示文摘Nonalcoholic fatty liver disease(NAFLD)is the leading cause of chronic liver disease worldwide among children and adolescents.It encompasses a spectrum of disease,from its mildest form of isolated steatosis,to nonalcoholic steatohepatitis(NASH)to liver fibrosis and cirrhosis,or end-stage liver disease.The early diagnosis of pediatric NAFLD is crucial in preventing disease progression and in improving outcomes.Currently,liver biopsy is the gold standard for diagnosing NAFLD.However,given its invasive nature,there has been significant interest in developing noninvasive methods that can be used as accurate alternatives.Here,we review noninvasive biomarkers in pediatric NAFLD,focusing primarily on the diagnostic accuracy of various biomarkers as measured by their area under the receiver operating characteristic,sensitivity,and specificity.We examine two major approaches to noninvasive biomarkers in children with NAFLD.First,the biological approach that quantifies serological biomarkers.This includes the study of individual circulating molecules as biomarkers as well as the use of composite algorithms derived from combinations of biomarkers.The second is a more physical approach that examines data measured through imaging techniques as noninvasive biomarkers for pediatric NAFLD.Each of these approaches was applied to children with NAFLD,NASH,and NAFLD with fibrosis.Finally,we suggest possible areas for future research based on current gaps in knowledge. | Dulshan Jayasekera Phillipp Hartmann | 2023 | World Journal of Hepatology2023，15，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员